Forecast
| Buy |
5 |
| Hold |
3 |
| Sell |
2 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsIn 2026, Dr Reddy's Laboratories Ltd has already paid €0.0733 in dividends. The last payout was in July.
Financials
In the last quarter, Dr Reddy's Laboratories Ltd had revenue of €798M and net profit of €85.13M
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 798M | 5.51% |
| Gross profit | 416.03M | 9.90% |
| Net profit | 85.13M | 38.24% |
| EBITDA | 157.96M | 32.25% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €11.4B |
Number of shares | 833.66M |
52-week high/low | €13.91 - €10.83 |
Dividends TTM | €0.0733 |
Beta | 0.24 |
P/E ratio | 41.38 |
PEG ratio | -0.79 |
P/B ratio | 3.00 |
P/S ratio | 3.51 |
Company profile
| Name | Dr Reddy's Laboratories Ltd |
| CEO | Erez Israeli |
| Headquarters | Hyderabad,
ts India |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Employees | 27,527 |